PET scan study for aggressive lymphoma patients
Part of Blood & lymphatic, Cancer clinical trials.
This study uses a special PET/CT scan to look at the environment around your lymphoma. The goal is to see if this scan can predict how well your treatment will work and your long-term outcome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an aggressive type of lymphoma.
- Your baseline PET/CT scan shows moderate to high FDG uptake (activity) in the lymphoma spots.
- You have not had any other cancers before.
- Your heart, liver, and kidneys are working normally.
- Your doctor expects you to live at least 6 months and you can complete follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of PET scan using a special tracer called Al18F-NOTA-FAPI-04 to see if it can better detect cancer, heart disease, or immune system conditions. The goal is to find out how well this imaging method works for diagnosis or monitoring of these diseases.
This early-phase study tests a special whole-body scan (PET/CT) that uses injected tracers to help show where lung cancer may be. It may help researchers see tumors more clearly and compare different tracers during the same time window.
This study uses a special type of scan (F-18 FDG PET/CT) to better understand metabolism in adults with lymphoma. The results may help doctors plan treatment more effectively.
This trial looks at whether PET/CT scans can better predict outcomes in people with fast-growing lymphoma. If you are newly diagnosed and receiving standard treatment, the study may help refine how response is evaluated.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This study tests a new kind of PET/CT scan that uses a tracer called 18F-FAPI to see if it can better detect cancer in the lymph nodes under the arm after you've already had chemotherapy or targeted therapy before surgery. If successful, this could help doctors plan more precise surgery and avoid removing unnecessary lymph nodes.
Hear when a new Aggressive Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.